The public registers hold a second record for Gland Chemicals. The fuller profile, with 75 active US DMFs and 3 valid CEPs, is at Gland Pharma. Figures on this page cover only this record.
Gland Chemicals is an API manufacturer based in India. It holds 6 active US drug master files across a filed portfolio of 7 molecules. Its GMP standing is certified by CDSCO (India). Customs aggregates show $160K of exports covering 25 molecules to 5 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Kancheepuram, India | Not on file |
| kolar, India | Not on file |
| Malur, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Bortezomib | SFDA (Saudi Arabia), US FDA | 2 |
| Pemetrexed | SFDA (Saudi Arabia), US FDA | 2 |
| Dexmedetomidine | SFDA (Saudi Arabia) | 1 |
| Ertapenem | US FDA | 1 |
| Gemcitabine | US FDA | 1 |
| Meropenem | US FDA | 1 |
| Rocuronium | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | None | 4 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $51K | 3 |
| 2025 | Not reported | $160K | 5 |
| 2024 | Not reported | $43K | 3 |
| 2023 | Not reported | $122K | 5 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Gland Chemicals comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.